Edition:
United States

Natco Pharma Ltd (NATP.NS)

NATP.NS on National Stock Exchange of India

793.80INR
23 Mar 2017
Change (% chg)

-- (--)
Prev Close
Rs793.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
345,095
52-wk High
Rs830.00
52-wk Low
Rs390.00

Latest Key Developments (Source: Significant Developments)

Natco Pharma Sept qtr consol profit rises
Friday, 11 Nov 2016 04:16am EST 

Natco Pharma Ltd : Sept quarter consol net profit 665.5 million rupees . Sept –quarter consol net sales 4.15 billion rupees . Consol net profit in Sept quarter last year was 292.9 million rupees as per Ind-AS; consol net sales was 2.37 billion rupees .Consensus forecast for sept quarter consol net profit was 482.2 million rupees.  Full Article

Natco Pharma says Mylan invalidates two of Teva's Copaxone 40 mg/ml patents
Thursday, 25 Aug 2016 12:55am EDT 

Natco Pharma Ltd : Marketing partner Mylan invalidates two of Teva's Copaxone 40 mg/ml patents .  Full Article

Natco Pharma gets EIR for Chennai facility
Thursday, 25 Aug 2016 12:13am EDT 

Natco Pharma Ltd : Natco receives establishment inspection report for Chennai facility . Gets successful establishment inspection report for Chennai facility from FDA for February 2016 inspection .  Full Article

Natco Pharma June-qtr consol profit up about 70 pct
Tuesday, 9 Aug 2016 06:01am EDT 

Natco Pharma Ltd : June-quarter consol net profit 476.5 million rupees . June-quarter consol net sales 2.98 billion rupees . Consensus forecast for June-quarter consol net profit was 468 million rupees . Consol net profit in June-quarter last year was 280.7 million rupees as per Ind-AS; consol net sales was 2.16 billion rupees . Recommends interim dividend of 0.75 rupees per share .  Full Article

Natco Pharma gets FDA approval for generic Tamiflu
Wednesday, 3 Aug 2016 11:31pm EDT 

Natco Pharma Ltd : Natco receives final approval for generic Tamiflu .  Full Article

Natco Pharma gets USFDA nod for generic version of Glycopyrrolate tablets
Thursday, 23 Jun 2016 03:26am EDT 

Natco Pharma Ltd : Clarifies on news item "Natco Pharma gets USFDA nod for glycopyrrolate" . Received from US agent on June 22 intimating approval for generic version of glycopyrrolate tablets 1mg and 2mg from US FDA . Glycopyrrolate to be manufactured at co's finished dosage facility located at kothur, near hyderabad, India . Believes the product will not have any material or financial impact on its operations . The market potential of the product is not significant" .  Full Article

Natco Pharma gets tentative US FDA nod for Sorafenib tablets, 200mg
Friday, 3 Jun 2016 04:15am EDT 

Natco Pharma Ltd : Gets tentative US FDA nod for sorafenib tablets, 200mg .  Full Article

Natco Pharma March-qtr consol profit up about 11 pct
Thursday, 26 May 2016 07:42am EDT 

Natco Pharma Ltd : March-quarter consol net profit 602.4 million rupees;March-quarter consol net sales 3.87 billion rupees . Consensus forecast for March-quarter consol net profit was 489.5 million rupees .  Full Article

Natco Pharma Ltd fixes record date for interim dividend
Thursday, 11 Feb 2016 03:54am EST 

Natco Pharma Ltd:Says that the company has fixed Feb. 23, 2016 as record date for the purpose of payment of interim dividend.Says interim dividend pay-by-date is March 03, 2016.  Full Article

Natco Pharma Ltd declares interim dividend
Wednesday, 10 Feb 2016 05:39pm EST 

Natco Pharma Ltd:Says that the board has recommended payment of interim dividend of 1.25 Indian rupees on each equity share of 2 Indian rupees each for the year 2015-2016.  Full Article

More From Around the Web

BRIEF-Natco Pharma Dec-qtr consol profit soars

* Natco pharma ltd consensus forecast for dec quarter consol net profit was 818.4 million rupees